Why is Arvee Laborat. falling/rising?

As of 30-Sep, Arvee Laboratories (India) Ltd is experiencing a decline in its stock price, currently at 154.85, which represents a decrease of 8.15 or 5.0%. The stock has underperformed its sector by 4.41% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the delivery volume has significantly dropped by 85.42% compared to the 5-day average, indicating a lack of investor interest. Over the past week, the stock has seen a return of -10.03%, while its performance over the last year shows a decline of 13.01%, with profits falling by 9.3%. The company has a low debt-to-equity ratio, but its operating profit growth has been poor, averaging only 1.80% over the last five years, which raises concerns about its long-term growth prospects.
In the broader market context, the Sensex has only declined by 2.22% over the past week, suggesting that Arvee Laboratories' performance is significantly worse than the overall market. While the stock has shown strong returns over a three-year and five-year period, the recent negative trends in sales and profitability, coupled with an expensive valuation relative to its peers, contribute to the current downward pressure on the stock price. The lack of positive momentum and falling investor participation further exacerbate the situation, indicating that investors are wary of the company's future performance.